Yale Medicine Inaugurates Distinguished Clinical Career Award
The new Yale Medicine Distinguished Clinical Career Award was created this year to recognize and honor the careers of physicians marked by significant accomplishments, exemplary dedication, and important contributions in advancing Yale Medicine, the overall medical profession, and the community.
Is Prevention the Future of SGLT2s? Inzucchi Offers Data That Suggest "Yes"
Groundbreaking trials with SGLT2 inhibitors show patients who did not have type 2 diabetes (T2D) when they started the DAPA-HF trial were 32% less likely to develop the disease if they took dapagliflozin (Farxiga) instead of placebo.Source: AJMC
Yale researchers help restore hormonal balance disrupted in metabolic diseases
Now Yale scientists report March 4 in the journal Nature that they have discovered the molecular mechanisms that trigger metabolic imbalance between these two distinct but linked processes, a finding with implications for the treatment of diabetes and non-alcoholic fatty liver disease (NAFLD).
Cancer and Obesity: The Link is Insulin
Nearly 40 percent of Americans over the age of 20 are obese, and another 32 percent are overweight. These alarming figures grow darker when combined with statistics showing that obesity is second only to smoking as a cause of preventable cancer deaths. Obesity has been linked to more than a dozen types of cancer.
Writing a song about weak bones and strong wills helped a Schnecksville musician cope with his rare disease
When Chris Younger was a child, he didn’t understand why he was bowlegged, shorter than everyone else and couldn’t run the bases in Little League as fast as other kids. He was 18 when he first heard his diagnosis of X-linked hypophosphatemia (XLH), a rare genetic form of rickets that affects muscles and teeth due to loss of phosphate. But doctors in the 1980s had a limited understanding of the disease and its symptoms.Source: The Morning Call